Mr Viet Ngoc Nguyen

Karolinska Institute, Stockholm (Sweden)

Follow

Contributor content

Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry

Presentation

Real-world eligibility for vericiguat according to trial, guideline, and labelling eligibility criteria: data from the Swedish Heart Failure Registry

ESC 365 is supported by

novartis

Explore sponsored resources